SMTL ID : 4hbp.1

Crystal Structure of FAAH in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.91 Å

Oligo State

homo-dimer

Ligands

2 x 17J: 4-(3-phenyl-1,2,4-thiadiazol-5-yl)-N-(pyridin-3-yl)piperazine-1-carboxamide(Covalent)

17J.1: 14 residues within 4Å: Chain A: M.162, L.163, S.164, F.165, D.208, I.209, G.210, G.211, S.212, F.352, L.375, M.407, T.459, I.462 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.352, A:L.375, A:T.459, A:I.462 Hydrogen bonds: A:I.209, A:G.210, A:G.211, A:S.212 17J.2: 12 residues within 4Å: Chain B: S.164, F.165, G.187, D.208, I.209, G.210, G.211, S.212, F.352, M.407, T.459, I.462 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:F.352, B:T.459, B:I.462 Hydrogen bonds: B:I.209, B:G.210, B:G.211, B:S.212

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kono, M. et al., Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors. Bioorg.Med.Chem. (2013)

Release Date

2013-02-06

Peptides

Fatty-acid amide hydrolase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Fatty-acid amide hydrolase 1